GlycoMimetics, Inc. GLYC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

40/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

GlycoMimetics, Inc. (GLYC) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ACHL, ANTX, ASMB, BCAB, CUE, DYN 等.

GLYC 的市值为 $1.01B, 而同行平均市值为 $616.08M. GLYC 显著大于其平均同行.

同行与相似公司 — GLYC

ACHL

Achilles Therapeutics plc

$1.48 +0.68% $60.83M

ANTX

AN2 Therapeutics, Inc.

$2.98 -1.00% $81.66M

ASMB

Assembly Biosciences, Inc.

Dyne Therapeutics, Inc.

$19.81 +4.26% $3.27B

FHTX

Foghorn Therapeutics Inc.

$4.85 +3.41% $284.7M

IVA

Inventiva S.A.

$5.51 +9.98% $286.42M

LIFE

aTyr Pharma, Inc.

$14.69 +2.23% $923.38M

MLYS

Mineralys Therapeutics, Inc.

$27.32 +0.59% $1.81B

NLTX

Neoleukin Therapeutics, Inc.

$3.49 +1.45% $8.2M

SPRO

Spero Therapeutics, Inc.

$2.78 -0.36% $160.94M

其他人也在看

DYN

Dyne Therapeutics, Inc.

$19.81

+4.26%

MLYS

Mineralys Therapeutics, Inc.

$27.32

+0.59%

TRVI

Trevi Therapeutics, Inc.

Assembly Biosciences, Inc.

Foghorn Therapeutics Inc.

$4.85

+3.41%

SPRO

Spero Therapeutics, Inc.

$2.78

-0.36%

GlycoMimetics, Inc. GLYC NASDAQ

同行与相似公司 — GLYC

其他人也在看

获取低估股票提醒